http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108276468-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1b42b99f08809982bb132fad0109baa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
filingDate 2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a5a1eecf9429387a9caa7fdeb745979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d390c8658523d8f19baafeefd22a0e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0a57fddd25d8fb70c78001dbc6e9c8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a65ad53cf74a7b79039f421ef6c9fcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f36b800ab6e8dea92fa8fa258c2f1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ad556cb5ce469b64c867b970dae904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aed15186b17e1b0f95032e1a79fce4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e11dfa58d1b5493f49704439961f4c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b54f6d9610435bdff332a6242bf66e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada51d9a88410183e60aec4caa842b36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d89a6664d5a8e77ddc55c23c8dd1b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f4c9870a033790a0c946f98fa26f3c
publicationDate 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108276468-A
titleOfInvention A kind of glycyrrhetinic acid ester, its preparation method and its application in the preparation of antiviral drugs
abstract The invention discloses a glycyrrhetinic acid ester, which has the following chemical structural formula: It can be obtained by reacting hexalizarin and glycyrrhetinic acid in an oil-water two-phase system composed of a water-insoluble organic solvent and an alkaline aqueous solution. The compound is almost non-toxic, has good curative effect on chicken bursal disease, is better than glycyrrhetinic acid, and can be used as a new medicine for treating chicken bursal disease.
priorityDate 2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016184400-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2258713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012020021-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468149304

Total number of triples: 27.